Application | Comment | Organism |
---|---|---|
medicine | subtype BoNT/A2 has greater clinical therapeutic value for treating subjects with Parkinson's disease compared to that ofsubtype BoNT/A1 | Clostridium botulinum |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
SNAP-25 + H2O | Clostridium botulinum | - |
? | - |
? | |
SNAP-25 + H2O | Clostridium botulinum Chiba-H | - |
? | - |
? | |
SNAP-25 + H2O | Clostridium botulinum 62A | - |
? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Clostridium botulinum | P10845 | - |
- |
Clostridium botulinum | Q58GH1 | - |
- |
Clostridium botulinum 62A | P10845 | - |
- |
Clostridium botulinum Chiba-H | Q58GH1 | - |
- |
Purification (Comment) | Organism |
---|---|
anion exchange column chromatography | Clostridium botulinum |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
SNAP-25 + H2O | - |
Clostridium botulinum | ? | - |
? | |
SNAP-25 + H2O | - |
Clostridium botulinum Chiba-H | ? | - |
? | |
SNAP-25 + H2O | - |
Clostridium botulinum 62A | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
BoNT/A1 | - |
Clostridium botulinum |
BoNT/A2 | - |
Clostridium botulinum |
botulinum neurotoxin A subtype 1 | - |
Clostridium botulinum |
botulinum neurotoxin A subtype 2 | - |
Clostridium botulinum |